201 related articles for article (PubMed ID: 33775616)
1. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Zhou X; Zhang S; Fan J; Zhu X; Hu S
Clin Transplant; 2023 Nov; 37(11):e15121. PubMed ID: 37676427
[TBL] [Abstract][Full Text] [Related]
3. Hemorrhagic cystitis following allogeneic hematopoietic cell transplantation.
Lee GW; Lee JH; Choi SJ; Kim S; Seol M; Kim WK; Lee JS; Lee KH
J Korean Med Sci; 2003 Apr; 18(2):191-5. PubMed ID: 12692415
[TBL] [Abstract][Full Text] [Related]
4. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Gilis L; Morisset S; Billaud G; Ducastelle-Leprêtre S; Labussière-Wallet H; Nicolini FE; Barraco F; Detrait M; Thomas X; Tedone N; Sobh M; Chidiac C; Ferry T; Salles G; Michallet M; Ader F;
Bone Marrow Transplant; 2014 May; 49(5):664-70. PubMed ID: 24488049
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning.
Lam W; Storek J; Li H; Geddes M; Daly A
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28199755
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors for hemorrhagic cystitis in children with β-thalassemia major after allogeneic hematopoietic stem cell transplantation].
Chen XL; Luo XJ; Cao K; Huang T; Luo YG; Yang CL; Chen YS
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Oct; 25(10):1046-1051. PubMed ID: 37905762
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient.
Maziarz RT; Devine S; Garrison LP; Agodoa I; Badaracco J; Gitlin M; Perales MA
Transplant Cell Ther; 2023 Oct; 29(10):637.e1-637.e9. PubMed ID: 37364775
[TBL] [Abstract][Full Text] [Related]
9. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
10. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Cidofovir in Treatment of BK Virus-Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients.
Coomes EA; Wolfe Jacques A; Michelis FV; Kim DDH; Thyagu S; Viswabandya A; Lipton JH; Messner HA; Deotare U
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1901-1905. PubMed ID: 29679772
[TBL] [Abstract][Full Text] [Related]
12. Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation.
Yu J; Judy JT; Parasuraman S; Sinha M; Weisdorf D
Biol Blood Marrow Transplant; 2020 Mar; 26(3):600-605. PubMed ID: 31678539
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP
Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666
[TBL] [Abstract][Full Text] [Related]
14. Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation.
Salamonowicz-Bodzioch M; Frączkiewicz J; Czyżewski K; Zając-Spychała O; Gorczyńska E; Panasiuk A; Ussowicz M; Kałwak K; Szmit Z; Wróbel G; Kazanowska B; Chybicka A; Ukielska-Hoffmann B; Wendycz-Domalewska D; Wysocki M; Dziedzic M; Wachowiak J; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Styczyński J
Ann Hematol; 2021 May; 100(5):1283-1293. PubMed ID: 33661334
[TBL] [Abstract][Full Text] [Related]
15. Severe hemorrhagic cystitis caused by the BK polyomavirus is associated with decreased survival post-allogeneic hematopoietic stem cell transplantation.
Kerbauy LN; Kerbauy MN; Bautzer V; Chapchap EC; de Mattos VRP; da Rocha JDA; Esteves I; Kutner JM; Kerbauy FR; Ribeiro AAF; Machado CM; Hamerschlak N; Santos FPS
Transpl Infect Dis; 2019 Oct; 21(5):e13101. PubMed ID: 31054192
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis.
Johnson BH; Taylor A; Kim G; Drahos J; Yang J; Akbari M; Shah NN
Biol Blood Marrow Transplant; 2019 Apr; 25(4):834-841. PubMed ID: 30625389
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and risk factors of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation].
Wu Q; Zhou F; Song NX; Liu XM; Yu Z; Song XC; Li X; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):187-190. PubMed ID: 30929383
[No Abstract] [Full Text] [Related]
19. Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation.
Peffault De Latour R; Chevallier P; Blaise D; Alami S; Lévy-Bachelot L; Allavoine T; Tadmouri A; Blomkvist J; Duhamel A; Srour M; Beauvais D; Yakoub-Agha I
J Med Virol; 2020 Dec; 92(12):3665-3673. PubMed ID: 32297984
[TBL] [Abstract][Full Text] [Related]
20. The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.
Uhm J; Hamad N; Michelis FV; Shanavas M; Kuruvilla J; Gupta V; Lipton JH; Messner HA; Seftel M; Kim DD
Bone Marrow Transplant; 2014 Dec; 49(12):1528-34. PubMed ID: 25111517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
